Anti-TORC2 antibody [EPR20219]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal TORC2 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 2 publications.
View Alternative Names
TORC2, CRTC2, CREB-regulated transcription coactivator 2, Transducer of regulated cAMP response element-binding protein 2, TORC-2, Transducer of CREB protein 2
- WB
Supplier Data
Western blot - Anti-TORC2 antibody [EPR20219] (AB184239)
Exposure times : Lanes 1, 2 : 3 minutes; Lane 3 : 15 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TORC2 antibody [EPR20219] (ab184239) at 1/1000 dilution
Lane 1:
Human fetal heart tissue lysate at 20 µg
Lane 2:
Human fetal kidney tissue lysate at 20 µg
Lane 3:
Human fetal brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/10000 dilution
Predicted band size: 73 kDa
Observed band size: 78 kDa
true
- WB
Supplier Data
Western blot - Anti-TORC2 antibody [EPR20219] (AB184239)
Exposure times : Lanes 1-3 : 10 seconds; Lanes 4-9 : 3 minutes.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TORC2 antibody [EPR20219] (ab184239) at 1/1000 dilution
Lane 1:
A20 (mouse reticulum sarcoma cell line) whole cell lysate at 20 µg
Lane 2:
CTLL-2 (mouse T lymphocyte cell line) whole cell lysate at 20 µg
Lane 3:
YAC-1 (mouse Moloney murine leukemia virus induced lymphoma lymphoblast cell line) whole cell lysate at 20 µg
Lane 4:
Neuro-2a (mouse neuroblastoma cell line) whole cell lysate at 20 µg
Lane 5:
C6 (rat glial tumor cell line) whole cell lysate at 20 µg
Lane 6:
L6 (rat skeletal muscle cell line) whole cell lysate at 20 µg
Lane 7:
A-673 (human muscle Ewing's Sarcoma cell line) whole cell lysate at 20 µg
Lane 8:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 9:
Raji (human Burkitt's lymphoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 73 kDa
Observed band size: 78 kDa
true
- WB
Supplier Data
Western blot - Anti-TORC2 antibody [EPR20219] (AB184239)
Exposure times : Lanes 1-6 : 3 minutes; Lanes 7-9 : 15 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TORC2 antibody [EPR20219] (ab184239) at 1/1000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Mouse spleen lysate at 10 µg
Lane 4:
Rat brain lysate at 10 µg
Lane 5:
Rat kidney lysate at 10 µg
Lane 6:
Rat spleen lysate at 10 µg
Lane 7:
RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 20 µg
Lane 8:
PC-12 (rat adrenal gland pheochromocytoma cell line) whole cell lysate at 20 µg
Lane 9:
NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 73 kDa
Observed band size: 78 kDa
true
Related conjugates and formulations (1)
-
Anti-TORC2 antibody [EPR20219] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The actions of TORC2 play important roles in the regulation of lipid metabolism cytoskeletal organization and stress response. This complex contributes to cell survival and proliferation by phosphorylating specific substrates that control these processes. TORC2 specifically phosphorylates the hydrophobic motif on actor proteins like Akt which is necessary for their full activation. This activity establishes TORC2 as an important regulator within numerous cellular systems that contribute to maintaining cellular integrity and homeostasis.
Pathways
The activities of TORC2 are integral to the PI3K/Akt signaling and insulin signaling pathways. Within these pathways TORC2's phosphorylation of Akt impacts glucose metabolism protein synthesis and cell survival. It operates in parallel with TORC1 (Target of Rapamycin Complex 1) yet TORC2 responds to distinct extracellular cues highlighting its unique role. Key proteins associated with TORC2 in these pathways include PI3K upstream and Akt downstream which are essential for transmitting signals that affect cell growth and metabolic regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Molecular neurobiology 62:11099-11111 PubMed40261603
2025
Applications
Unspecified application
Species
Unspecified reactive species
Metabolism: clinical and experimental 152:155772 PubMed38176644
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com